Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma FDA Action Update, January 2026: Approvals, Acceptance, and Clearance NeurologyLive Clinical Neurology News and Neurology Expert Insights FDA Peptide Ban Lifted: Legit Compounding Pharmacies Now Regulate Julian Becerra posted on the topic LinkedIn The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what Potential FDA Peptide Reclassification 2026 What It Means for Patients Beverly Hills Rejuvenation Center GHK Cu Peptide Therapy Brea, CA Orange County